Anika Therapeutics(ANIK) - 2025 Q4 - Earnings Call Transcript

Anika Therapeutics (NasdaqGS:ANIK) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsIan W. McLeod - SVP, Chief Accounting Officer and TreasurerMatt Hall - Executive Director of Corporate Development and Investor RelationsSteve Griffin - President and CEOConference Call ParticipantsAnderson Schock - MedTech Equity Research AnalystMichael Petusky - Managing Director and Senior Research AnalystOperatorGood morning, ladies and gentlemen, and welcome to Anika's fourth quarter and year-end ...